Page last updated: 2024-11-04

sarpogrelate and Low Back Pain

sarpogrelate has been researched along with Low Back Pain in 2 studies

sarpogrelate: structure given in first source

Low Back Pain: Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Forty patients with sciatica due to L4-5 or L5-S1 disc herniation were randomly allocated to treatment with the 5-HT2A inhibitor (sarpogrelate 300 mg/day) or nonsteroidal antiinflammatory drugs (NSAIDs; diclofenac 75 mg/day)."5.11New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial. ( Hashimoto, T; Kanayama, M; Oha, F; Shigenobu, K; Yamane, S, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanayama, M2
Hashimoto, T2
Shigenobu, K2
Yamane, S2
Oha, F1

Trials

1 trial available for sarpogrelate and Low Back Pain

ArticleYear
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial.
    Journal of neurosurgery. Spine, 2005, Volume: 2, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nerve Block; Diclofenac; Epidural Space; F

2005

Other Studies

1 other study available for sarpogrelate and Low Back Pain

ArticleYear
Efficacy of serotonin receptor blocker for symptomatic lumbar disc herniation.
    Clinical orthopaedics and related research, 2003, Issue:411

    Topics: Adult; Female; Humans; Hypesthesia; Intervertebral Disc Displacement; Low Back Pain; Magnetic Resona

2003